BLACK ROSE INDUSTRIES LTD. Q4 FY26 Results

Summary

Blackrose Chemicals reported a resilient performance for FY26, despite a 17.4% moderation in consolidated revenue to ₹325.85 crore due to correcting chemical prices. The company's consolidated profit after tax, however, grew by 5.8% to ₹22.42 crore, supported by operational efficiencies and a favorable product mix. Standalone results for Q4 FY26 showed significant sequential growth, with revenue up 38.1% to ₹104.78 crore and PAT soaring by 113.6% to ₹9.42 crore. The manufacturing division was a key growth driver, increasing revenue by 20.4% and EBITDA by 45.9% in FY26, while standalone EBITDA margin improved to 10.97%. The company strengthened its global reach and product pipeline, positioning itself for long-term growth.

Key Highlights

1. 1

   Consolidated revenue for FY26 moderated by 17.4% to ₹325.85 crore compared to ₹394.71 crore in FY25, primarily due to a correction in chemical prices.

2. 2

   Consolidated profit after tax (PAT) for FY26 grew by 5.8% to ₹22.42 crore, up from ₹21.20 crore in the previous fiscal year.

3. 3

   Standalone revenue for Q4 FY26 increased significantly by 38.1% to ₹104.78 crore over Q3 FY26's ₹75.86 crore.

4. 4

   Standalone profit after tax (PAT) more than doubled in Q4 FY26, soaring by 113.6% to ₹9.42 crore from ₹4.41 crore in Q3 FY26.

5. 5

   The standalone manufacturing division delivered strong growth in FY26, with revenue increasing by 20.4% to ₹114.10 crore and EBITDA rising by 45.9% to ₹25.06 crore.

6. 6

   Standalone EBITDA margin improved to 10.97% in FY26, up from 9.70% in FY25, reflecting enhanced operational efficiencies and a favorable product mix.

7. 7

   The company strategically exited the ceramic binder business in Morbi to prioritize upstream acrylamide and higher-value opportunities across diversified end-uses.